Shanghai Genechem Co., Ltd. (Genechem) Announces Global Collaboration on Bispecific Antibodies
PR88868
SHANGHAI, April 6, 2021 /PRNewswire=KYODO JBN/ --
Shanghai Genechem Co., Ltd. (Genechem), a discovery company dedicated to novel
drug target discovery and development of novel therapeutics, today announced
the execution of a global collaboration with I-Mab (Nasdaq: IMAB), a
Nasdaq-listed global biopharmaceutical company, to develop and commercialize
multiple bi-specific antibodies (BsAb) based on monoclonal antibody developed
by Genechem and antibodies selected by I-MAB.
"This collaboration is the first of many that will leverage Genechem's Good
Research Practice (GRP) and CHAMP antibody discovery platform, strong
bioinformatic database, as well as strong development expertise of synergistic
partners, to deliver globally competitive assets based on innovative targets.
We are excited to collaborate with I-Mab, a global leader in Oncology and
antibody development, to bring more products to address clinical unmet needs
for patients in China and globally", commented Yueqiong Cao, Founder and CEO of
Genechem.
About Shanghai Genechem Co., Ltd. (Genechem)
Genechem is a leading innovation research company focused on target
discovery/validation, development of antibody and cell therapy products against
novel targets, and partnership globally to maximize its portfolio. Founded in
2002, now with over 500 employees, Genechem works closely with Research
Oncologists to translate clinical research into therapeutics addressing high
clinical unmet needs, leveraging its strong network of Research Oncologists in
over 300 hospitals and Good Research Practice (GRP platform) which includes
comprehensive RNAi library, tools including genetic typing, bioinformatic
analysis, genetic manipulation, as well as SOP and project management systems.
For more information, visit http://www.gcbio.com/.
Contact:
Dr. Tong Zhang
Chief Business Officer
Shanghai Genechem Co., Ltd
Tong.zhang@genechem.com.cn
+86-18501607878
Source: Shanghai Genechem Co., Ltd. (Genechem)
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。